Clinical trial
V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis
NCT00175513 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00175513 |
|---|---|
| Title | V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis |
| Official title | V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psychosis |
| Intervention type | Drug |
| Interventions | Valacyclovir (Valtrex) |
| Enrollment | 100 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 14, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: